Medtronic (NYSE:MDT) said it’s closed a $66 million investment in Chinese medical device company LifeTech Scientific (HK:8122).
Funding Roundup
The “don’ts” of pitching a new technology, according to Dr. Thomas Fogarty
This article is an excerpt from a blog post originally published on biodesignalumni.com
Second Sight eyes $25M funding round | Wall Street Beat
Second Sight Medical registered with the SEC for a $25 million offering of equity, debt, options and warrants as it waits for the FDA to decide whether to give the green light to its "bionic eye" retinal implant.
The Sylmar, Calif.-based medical device company filed with the securities watchdog agency yesterday, saying it has yet to sell any of the $1,000 shares in the offering.
Ocular Therapeutix eyes a $24M Series D extension | Wall Street Beat
Ocular Therapeutix said it closed a $23.8 million Series D extension round from existing backers for its sustained drug release technology to treat eye diseases.
The Bedford, Mass.-based medical device company said all of its current institutional investors ponied up for the round, including Polaris Ventures, Versant Ventures, SV Life Sciences, Sparta LLC, and Ascension Health Ventures.
Ocular Therapeutix is developing a punctum plug for the entry of the tear duct to release drug therapy to the surface of the eye over several months.
SpinalMotion closes 4th tranche of $15M round | Wall Street Beat
SpinalMotion closed the final tranche of a $15 million funding round that began in June 2011, according to a regulatory filing.
The Mountain View, Calif.-based medical device company raised a total of $15.1 million in the offering of debt, options and warrants from 15 unnamed investors, according to the filing.
Medical device angel investments jump in 2012
The medical device industry isn’t being left behind when it comes to angel investing, according to data provided to MassDevice.com from the investment data firm CB Insights.
Angel- and seed-round financing (typically $1.5 million or less) jumped dramatically in 2012, accounting for about 27% of all investment in the medical device industry. That’s a 50% increase compared with 2011.
Venture capital: Deal flow jumps during 4th quarter of 2012
Investors returned to the medical device industry during the final quarter last year, despite negative headwinds, according to new data released by CB Insights, a venture capital and angel investment database.
Companies in the medical device space closed 68 deals during the final 3 months of 2012, up 41% from the previous quarter about 3% from the same period in 2011, making Q4 the most active quarter of 2012.
AtriCure prices $24M stock offering | Wall Street Beat
AtriCure (NSDQ:ATRC) priced a public offering of nearly 3.5 million shares of stock at $7.25 per share, saying it expects net proceeds of about $23.5 million.
The West Chester, Ohio-based medical device company said it granted underwriter Piper Jaffray a 30-day over-allotment option for another 521,000 shares.
St. Jude Medical seesaws on FDA warning letter
A warning letter from the FDA to St. Jude Medical (NYSE:STJ) sent the St. Paul, Minn.-based medical device company’s stock on a seesaw ride yesterday and today.
STJ shares closed up 1.5% yesterday at $38.85 each after St. Jude revealed the warning letter, but closed down 1.2% today at $38.39 apiece.
SPR Therapeutics raises $5M Series A round
Cleveland-area startup SPR Therapeutics closed a $7.8 million Series A financing round to commercialize its neurostimulation pain relief device.
The funding came from NDI Healthcare Fund, Public Square Partners and individual investors, according to a press release.
Monteris Medical closes $7.8M round for brain tumor laser
Monteris Medical closed a $7.8 million funding round it plans to use to commercialize its NeuroBlate neurosurgical ablation device for treating brain tumors.
The round, led by Business Development Bank of Canada, also included the SWMF Life Science Fund and several independent parties. Monteris drummed up $9 million last May, according to a press release.
Sign up to get our free newsletters delivered right to your inbox.
[sead]